Authors

1. Smart , Hiske
2. Sibbald , R. Gary
3. Goodman , Laurie
4. Ayello , Elizabeth A.
5. Jaimangal , Reneeka
6. Gregory , John H.
7. Akita , Sadanori
8. Alavi , Afsaneh
9. Armstrong , David G.
10. Arputhanathan , Helen
11. Bruwer , Febe
12. Caul , Jeremy
13. Chan , Beverley
14. Cronje , Frans
15. Dofitas , Belen
16. Hamed , Jassin
17. Harley , Catherine
18. Heil , Jolene
19. Hill , Mary
20. Jahnke , Devon
21. Kalina , Dale
22. Kodange , Chaitanya
23. Kotru , Bharat
24. Kozody , Laura Lee
25. Landis , Stephan
26. LeBlanc , Kimberly
27. MacDonald , Mary
28. Mark , Tobi
29. Martin , Carlos
30. Mayer , Dieter
31. Murphy , Christine
32. Nair , Harikrishna
33. Orellana , Cesar
34. Ostrow , Brian
35. Queen , Douglas
36. Rainville , Patrick
37. Rajhathy , Erin
38. Schultz , Gregory
39. Somayaji , Ranjani
40. Stacey , Michael C.
41. Tariq , Gulnaz
42. Weir , Gregory
43. Whiteside , Catharine
44. Yifter , Helen
45. Zacharias , Ramesh

Abstract

After participating in this educational activity, the participant will:1. Summarize issues related to wound assessment.2. Identify a class of drugs for the treatment of type II diabetes mellitus that has been shown to improve glycemia, nephroprotection, and cardiovascular outcomes.3. Synthesize strategies for wound management, including treatment in resource-limited settings.4. Specify the target time for edge advancement in chronic, healable wounds.